Menu Menu


/ News
Monday, 6th July 2020 | 1,272 veterinary jobs online | 145 people actively seeking work | 5,028 practices registered

Veterinary Industry News

Send us your news


10 months ago

4th September, 2019 15h49


Dechra Veterinary Products has added a new injectable acepromazine to its extensive equine anaesthesia and analgesia range.

Tranquinervin®, which contains 10 mg/ml acepromazine, is indicated for anaesthetic premedication, tranquilisation and sedation.

Emma Jennings, Brand Manager at Dechra said: “Tranquinervin provides tranquillisation or a mild sedation for several hours, making it a valuable tool for many day-to-day veterinary scenarios.

“At low doses, acepromazine reduces anxiety which is beneficial for use in horses prior to shoeing or transportation. At higher dose rates, it is an effective sedative for use in situations like dentistry or handling. The relaxant effects also aid examination of the penis in horses and the treatment of tetanus and choke.

“There is also reduced anaesthetic risk reported following sole premedication with acepromazine in healthy horses1.”

Tranquinervin is available in a 20 ml vial with a 56 day broached shelf life.

It can be used in conjunction with Dechra’s equine anaesthesia and analgesia app that is designed to help veterinary professionals choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates quickly and easily. 

Tranquinervin is part of Dechra’s extensive equine anaesthesia and analgesia range that includes Domidine® and Relaquine®. For more information, go to:

More from Dechra